Literature DB >> 10896950

Glucocorticoid-mediated destabilization of cyclin D3 mRNA involves RNA-protein interactions in the 3'-untranslated region of the mRNA.

E A Garcia-Gras1, P Chi, E A Thompson.   

Abstract

Glucocorticoids regulate the expression of the G(1) progression factor, cyclin D3. Cyclin D3 messenger RNA (CcnD3 mRNA) stability decreases rapidly when murine T lymphoma cells are treated with the synthetic glucocorticoid dexamethasone. Basal stability of CcnD3 mRNA is regulated by sequences within the 3'-untranslated region (3'-UTR). RNA-protein interactions occurring within the CcnD3 3'-UTR have been analyzed by RNA electrophoretic mobility shift assay. Three sites of RNA-protein interaction have been mapped using this approach. These elements include three pyrimidine-rich domains of 25, 26, and 37 nucleotides. When the cyclin D3 3'-UTR was stably overexpressed, the endogenous CcnD3 mRNA was no longer regulated by dexamethasone. Likewise, overexpression of a 215-nucleotide transgene that contains the 26- and 37-nucleotide elements blocks glucocorticoid inhibition of CcnD3 mRNA expression. These observations suggest that the 215-nucleotide 3'-UTR element may act as a molecular decoy, competing for proteins that bind to the endogenous transcript and thereby attenuating glucocorticoid responsiveness. UV-cross-linking experiments showed that two proteins of approximate molecular weight 37,000 and 52,000 bind to this 3'-UTR element.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10896950     DOI: 10.1074/jbc.m001048200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  Cell cycle control mechanisms in B-1 and B-2 lymphoid subsets.

Authors:  Michael J Piatelli; Debra Tanguay; Thomas L Rothstein; Thomas C Chiles
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

2.  Glucocorticoid regulation of human pulmonary surfactant protein-B mRNA stability involves the 3'-untranslated region.

Authors:  Helen W Huang; Weizhen Bi; Gaye N Jenkins; Joseph L Alcorn
Journal:  Am J Respir Cell Mol Biol       Date:  2007-11-15       Impact factor: 6.914

3.  Synergistic Drug Combinations with a CDK4/6 Inhibitor in T-cell Acute Lymphoblastic Leukemia.

Authors:  Yana Pikman; Gabriela Alexe; Giovanni Roti; Amy Saur Conway; Andrew Furman; Emily S Lee; Andrew E Place; Sunkyu Kim; Chitra Saran; Rebecca Modiste; David M Weinstock; Marian Harris; Andrew L Kung; Lewis B Silverman; Kimberly Stegmaier
Journal:  Clin Cancer Res       Date:  2016-11-09       Impact factor: 12.531

4.  Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38.

Authors:  M Lasa; M Brook; J Saklatvala; A R Clark
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

Review 5.  Advances in tryptophan hydroxylase-2 gene expression regulation: new insights into serotonin-stress interaction and clinical implications.

Authors:  Guo-Lin Chen; Gregory M Miller
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-03       Impact factor: 3.568

6.  Promotion of cell cycle progression by basic helix-loop-helix E2A.

Authors:  F Zhao; A Vilardi; R J Neely; J K Choi
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

7.  Glucocorticoids suppress T cell function by up-regulating microRNA-98.

Authors:  Trevor E Davis; Katalin Kis-Toth; Attila Szanto; George C Tsokos
Journal:  Arthritis Rheum       Date:  2013-07

8.  Translational repression of cyclin D3 by a stable G-quadruplex in its 5' UTR: implications for cell cycle regulation.

Authors:  Heng-You Weng; Hui-Lin Huang; Pan-Pan Zhao; Hui Zhou; Liang-Hu Qu
Journal:  RNA Biol       Date:  2012-08-01       Impact factor: 4.652

9.  Methods to study maternal regulation of germ cell specification in zebrafish.

Authors:  O H Kaufman; F L Marlow
Journal:  Methods Cell Biol       Date:  2016-03-02       Impact factor: 1.441

10.  Glucocorticoids regulate pentraxin-3 expression in human airway smooth muscle cells.

Authors:  Jingbo Zhang; Latifa Koussih; Lianyu Shan; Andrew J Halayko; Omar Tliba; Abdelilah S Gounni
Journal:  PLoS One       Date:  2019-08-22       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.